[ad_1] Boehringer Ingelheim laboratory The pharmaceutical company is currently researching a range of treatment options for Covid-19 lung disease caused by the new coronavirus. (Photo: Boehringer Ingelheim) Frankfurt Pharmaceutical company Boehringer Ingelheim is leading the development of a drug for patients with Covid-19. A Phase 2 clinical trial is to …
Read More »Boehringer leads the development of the corona drug
